• Sign In
  • Home
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
  • Policy
  • Opinion
    • Editorials
    • Op-Eds
  • In Focus
  • Restoring America
  • Magazine
  • Watch
  • Sponsored
    • Examining Tax Reform
    • Fix TSCA
    • National Parks
    • Inside the Corn Belt
  • TWS Archive
Search
LogoWashington Examiner
Subscribe
LogoWashington Examiner
Sign in
Subscribe
  • News
    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Entertainment
    • Washington Secrets
    • Sports
  • Policy
    • Defense
    • National Security
    • Energy and Environment
    • Education
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space
  • Trump Administration
  • IN FOCUS
  • Opinion
    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds
  • Restoring America
    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
  • Watch
  • Magazine
    • Magazine
    • Quarterly Briefing
    • Archives
    • Games
  • Sponsored
    • National Parks
    • Examining Tax Reform
    • Fix TSCA
    • Inside the Corn Belt
  • Newsletters
More
    Home Authors Posts by Matthew Pennington

    Matthew Pennington

    FILE - This Aug. 29, 2009 photo shows village malaria worker Phoun Sokha, 47, showing his malaria medicine kit at O'treng village on the outskirts of Pailin, Cambodia. This spot on the Thai-Cambodian border is home to a form of malaria that keeps rendering one powerful drug after another useless. This time, scientists have confirmed the first signs of resistance to the only affordable treatment left in the global medicine cabinet for malaria: Artemisinin. U.S. experts are raising the alarm over the spread of drug-resistant malaria in several Southeast Asian countries, endangering major global gains in fighting the mosquito-borne disease that kills more than 600,000 people annually. The report warns that could be a health catastrophe in the making, as no alternative anti-malarial drug is on the horizon. (AP Photo/David Longstreath, File)
    Healthcare

    Resistance to malaria drugs has spread in SE Asia

    Associated Press, Matthew Pennington -
    November 12, 2013 5:00 am
    0
    Pacific commander plans for NKorea missile threat
    News

    Pacific commander plans for NKorea missile threat

    Matthew Pennington -
    November 5, 2013 6:53 pm
    0
    UN panel told NKorea regime to blame for famine
    News

    UN panel told NKorea regime to blame for famine

    Matthew Pennington -
    October 31, 2013 10:05 pm
    0
    Jin hye Jo wipes a tear as she testifies during a hearing of the United Nations mandated Commission of Inquiry about the human rights situation in the Democratic People's Republic of Korea, at the Johns Hopkins School of Advanced International Studies, Wednesday, Oct. 30, 2013, in Washington. Jo wiped the tear while talking about her brother dying in her arms. (AP Photo/Alex Brandon)
    News

    NKorea defector testifies at UN rights probe in US

    Matthew Pennington -
    October 31, 2013 12:13 am
    0
    US looks to Asia nations to build their militaries
    National Security

    US looks to Asia nations to build their militaries

    Matthew Pennington -
    October 29, 2013 9:59 pm
    0
    This Oct. 9, 2013 satellite image taken by Astrium, and annotated and distributed by 38 North shows the Sohae site where North Korea launched a long-range rocket into space in December 2012. U.S.-Korea Institute at Johns Hopkins School of Advanced International Studies said Monday, Oct. 28, 2013, North Korea is conducting major construction at its main missile launch site, apparently to accommodate larger rockets and new mobile missiles. (AP Photo/Astrium - 38 North) MANDATORY CREDIT
    News

    Preoccupied Obama criticized over NKorea policy

    Matthew Pennington -
    October 29, 2013 7:03 am
    0
    Images show new work at NKorea’s nuclear test site
    News

    Images show new work at NKorea’s nuclear test site

    Matthew Pennington -
    October 23, 2013 4:30 pm
    0
    Cambodian opposition leader urges pressure on govt
    News

    Cambodian opposition leader urges pressure on govt

    Matthew Pennington -
    October 16, 2013 10:35 pm
    0
    India defends rules for foreign retailers
    News

    India defends rules for foreign retailers

    Matthew Pennington -
    October 10, 2013 8:21 pm
    0
    Institute: Further signs NKorea reactor restarted
    News

    Institute: Further signs NKorea reactor restarted

    Matthew Pennington -
    October 2, 2013 6:34 pm
    0
    1...8910...17Page 9 of 17
    LogoWashington Examiner
    Do Not Sell or Share My Personal Information
    Facebook
    Twitter
    Youtube

    NEWS

    • Politics
      • White House
      • Senate
      • House
      • Campaigns
    • Business
    • World
    • Investigations
    • Justice
    • Supreme Court
    • Crime
    • Washington Secrets
    • Entertainment
    • Sports

    POLICY

    • Defense
    • National Security
    • Energy
    • Immigration
    • Finance and Economy
    • Healthcare
    • Foreign Policy
    • Tech
    • Infrastructure
    • Space

    COMMENTARY

    • Columnists
    • Editorials
    • Think Tanks
    • Beltway Confidential
    • Op-Eds

    RESTORING AMERICA

    • Patriotism & Unity
    • Faith, Freedom & Self-Reliance
    • Courage, Strength & Optimism
    • Equality, Not Elitism
    • Community & Family
    • Fairness & Justice
    • Mission
    • WATCH
    • IN FOCUS
    • NEWSLETTERS
    • MAGAZINE ARCHIVE
    • Policies and Standards
    • Terms Of Service
    • Subscription Terms of Use
    • Privacy Policy
    • Your Privacy Choices
    • Transparency In Coverage
    • Advertise
    • Subscribe
    • Contact
    • Careers
    • Staff
    • About Examiner
    • Facebook
    • Twitter